TotalMarketCap

NuCana

NCNANasdaq United KingdomHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$3.887 M

$0.93 -8.43%

Close of 6 Nov 2026

As of 6 Nov 2026, NuCana (NCNA) has a market capitalization of $3.89M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

20,809,854,947

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #458Xtl BiopharmaceuticalsXTLB$4.22M
  2. #459Apimeds Pharmaceuticals USAPUS$4.05M
  3. #460NuCanaNCNA$3.89M
  4. #461Dermata TherapeuticsDRMA$3.82M
  5. #462RedHill BiopharmaRDHL$3.73M

What if NuCana were worth as much as…

Open the what-if tool →

Gold $28.2T

$6,784,495

Per share 7,263,914× higher

Bitcoin $1.53T

$367,097.23

Per share 393,038× higher

Apple $5.02T

$1,205,146

Per share 1,290,306× higher

Or at a round number

$5.00M$10.0M$20.0M$50.0M

Where these numbers come from

Share counts and financials for NuCana are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.